pubmed-article:1086231 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:1086231 | lifeskim:mentions | umls-concept:C0085979 | lld:lifeskim |
pubmed-article:1086231 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
pubmed-article:1086231 | lifeskim:mentions | umls-concept:C0542341 | lld:lifeskim |
pubmed-article:1086231 | lifeskim:mentions | umls-concept:C0301872 | lld:lifeskim |
pubmed-article:1086231 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:1086231 | pubmed:dateCreated | 1977-1-3 | lld:pubmed |
pubmed-article:1086231 | pubmed:abstractText | A small bifunctional antigen (4-hydroxy-5-iodo-3-nitrophenyl)acetyl-epsilon-aminocaproyl-L-tyrosine-azobenzene-p-arsonate [NIP-cap-TYR(ABA)] was found to induce fair humoral antibody formation against NIP-cap but very little anti-ABA-TYR. This was observed in rats and guinea pigs. Prior immunization with ABA-TYR, either as such or coupled to dodecanoylated bovine serum albumin (lipid-BSA), primed rats for an enhanced anti-NIP response to NIP-cap-TYR(ABA). An attempt to encourage rats to produce anti-ABA-TYR in response to the bifunctional antigen by priming them with NIP-cap-lipid-BSA failed. Priming with ABA-TYR was dose-dependent. An injection of 1.5-15 nanomoles per rat primed for an increased production of anti-NIP while 150 nanomoles did not. Adult thymectomized x-irradiated rats had a poor anti-NIP response to the bifunctional antigen if they were reconstituted with T-enriched lymphoid cells from control mice, but a good response if reconstituted with similar cells from ABA-TYR-primed syngeneic rats. | lld:pubmed |
pubmed-article:1086231 | pubmed:language | eng | lld:pubmed |
pubmed-article:1086231 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1086231 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:1086231 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1086231 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1086231 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1086231 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1086231 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:1086231 | pubmed:month | Apr | lld:pubmed |
pubmed-article:1086231 | pubmed:issn | 0014-2980 | lld:pubmed |
pubmed-article:1086231 | pubmed:author | pubmed-author:BeckerM JMJ | lld:pubmed |
pubmed-article:1086231 | pubmed:author | pubmed-author:RayAA | lld:pubmed |
pubmed-article:1086231 | pubmed:author | pubmed-author:AnderssonL... | lld:pubmed |
pubmed-article:1086231 | pubmed:author | pubmed-author:MAKELAOO | lld:pubmed |
pubmed-article:1086231 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:1086231 | pubmed:volume | 5 | lld:pubmed |
pubmed-article:1086231 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:1086231 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:1086231 | pubmed:pagination | 262-6 | lld:pubmed |
pubmed-article:1086231 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:1086231 | pubmed:meshHeading | pubmed-meshheading:1086231-... | lld:pubmed |
pubmed-article:1086231 | pubmed:meshHeading | pubmed-meshheading:1086231-... | lld:pubmed |
pubmed-article:1086231 | pubmed:meshHeading | pubmed-meshheading:1086231-... | lld:pubmed |
pubmed-article:1086231 | pubmed:meshHeading | pubmed-meshheading:1086231-... | lld:pubmed |
pubmed-article:1086231 | pubmed:meshHeading | pubmed-meshheading:1086231-... | lld:pubmed |
pubmed-article:1086231 | pubmed:meshHeading | pubmed-meshheading:1086231-... | lld:pubmed |
pubmed-article:1086231 | pubmed:meshHeading | pubmed-meshheading:1086231-... | lld:pubmed |
pubmed-article:1086231 | pubmed:meshHeading | pubmed-meshheading:1086231-... | lld:pubmed |
pubmed-article:1086231 | pubmed:meshHeading | pubmed-meshheading:1086231-... | lld:pubmed |
pubmed-article:1086231 | pubmed:meshHeading | pubmed-meshheading:1086231-... | lld:pubmed |
pubmed-article:1086231 | pubmed:meshHeading | pubmed-meshheading:1086231-... | lld:pubmed |
pubmed-article:1086231 | pubmed:meshHeading | pubmed-meshheading:1086231-... | lld:pubmed |
pubmed-article:1086231 | pubmed:meshHeading | pubmed-meshheading:1086231-... | lld:pubmed |
pubmed-article:1086231 | pubmed:meshHeading | pubmed-meshheading:1086231-... | lld:pubmed |
pubmed-article:1086231 | pubmed:year | 1975 | lld:pubmed |
pubmed-article:1086231 | pubmed:articleTitle | p-Azobenzenearsonate-L-tyrosine-mediated helper function in immune responses of guinea pigs and rats. | lld:pubmed |
pubmed-article:1086231 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:1086231 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1086231 | lld:pubmed |